| Time point |
---|
Variables/scales | Pre-treatment | Post-treatment | 3-month follow-up |
---|
Socio-demographics | X | Â | Â |
Drug use experience | X | Â | Â |
Urine test | Â | Â | X |
Self-report drug use | X | Â | X |
DAST 20 | X | Â | X |
ASI-SR | X | Â | X |
SRRS | X | X | X |
VAS for craving | X | X | X |
AUDIT | X | Â | X |
CBI-Drug | X | Â | X |
Brief COPE | X | X | X |
WHO-5 Well-being Index | X | X | X |
EQ-5D-5L | X | X | X |
BDI-II | X | X | X |
PoC | Â | X | Â |
- DAST Drug Abuse Screening Test, ASI-SR Addiction Severity Index-Self Report, SRRS Stimulant Relapse Risk Scale, VAS Visual Analogue Scale, AUDIT Alcohol Use Disorder Identification Test, CBI-Drug Coping Behaviors Inventory-Drug, COPE Coping Orientation to Problems Experienced, WHO-5 Well-being Index, the World Health Organization Five Well-being Index, EQ-5D-5L Five-level EQ-5D, BDI Beck Depression Inventory, PoC Perceptions of Care Surveys